Schering-Plough Highlights Hepatitis C Clinical Data Presentations …
April 27th, 2009
| Tags: Arthritis, chronic-hepatitis, fda-drug-alerts, gout, liver, patients, Pneumonia, primary, trial, united, uric acid
In this large, prospective, randomized , multinational clinical trial , slow responders were randomized at treatment week 36 to receive PEGINTRON combination therapy for a total of 48 weeks (n=86) (standard approved duration) or 72 weeks …. cellulitis); emphysema, bronchiolitis obliterans, pleural effusion, gastroenteritis, pancreatitis, gout , hyperglycemia, hyperthyroidism and hypothyroidism, autoimmune thrombocytopenia with or without purpura, rheumatoid arthritis , …
Continued here:
Schering-Plough Highlights Hepatitis C Clinical Data Presentations …
Leave a comment
| Trackback